Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic.

Richard M Bergenstal¹, Jennifer E Layne², Howard Zisser³, Robert A Gabbay⁴, Nathan A Barleen², Amy Armento Lee³, Amit R Majithia⁵, Christopher G Parkin⁶, Ronald F Dixon²

¹International Diabetes Center at Park Nicollet, HealthPartners Institute, Minneapolis, Minnesota, USA.

²Onduo, Newton, Massachusetts, USA.

³Verily Life Sciences, South San Francisco, California, USA.

⁴Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.

⁵University of California San Diego, School of Medicine, La Jolla, California, USA.

⁶CGParkin Communications, Inc., Clinical Affairs, Henderson, Nevada, USA.

PubMed PMC DOI PDF

Abstract

The Onduo Virtual Diabetes Clinic (VDC) for people with type 2 diabetes (T2D) combines a mobile app, remote lifestyle coaching, connected devices, and live video consultations with board-certified endocrinologists. Adults with T2D (n = 594) who were evaluated by a VDC endocrinologist, remotely prescribed and mailed a real-time continuous glucose monitoring (rtCGM) device and used ≥1 sensor complet…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.